Childhood Vaccines in India, Part 2
Part 2: Vaccination Challenges in Developing Countries
Developing countries generally wait an average of 20 years between when a vaccine is licensed in industrialized countries and when it is available for their own populations. Economic, infrastructural and scientific hurdles all contribute to this long delay. The Global Alliance for Vaccines and Immunization (GAVI) is a partnership between many public and private organization, including UNICEF, WHO, the Bill and Melinda Gates Foundation, members of the vaccine industry and NGOs. GAVI was formed in 1999 to address the long delay between vaccine availability in industrialized countries and developing countries. Scientific advances that would help make more vaccines available in developing countries include the development of temperature stable vaccines, development of vaccines that required less than three doses to immunize and the development of needle free methods to administer vaccines.
The Global Epidemic of TB
This article was originally published by Scientific American
Unless you’ve been distanced from the news and the internet, you have heard that tuberculosis has become increasingly drug resistant and is resurging in many areas of the world and this is much more than a minor inconvenience.
Kari Stoever, the Vice President of External Affairs at Aeras – a global nonprofit biotech advancing TB vaccines for the world, has put together a team to create an educational series of videos, which are available in its entirety for screenings, to raise awareness about the re-emerging infectiousness and virulence of pulmonary TB across the world.
12 years ago Blog, Health, Science, Travel • Tags: Aeras, child survival, DOT center, EXPOSED, India, International Reporting Project, Kari Stoever, mHealth, Molecules : The Elements and the Architecture of Everything, Mumbai, Scientific American, STEM, tuberculosis